Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 8-K Event Results of operations · Regulation FD disclosure
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 4 Open-market buy Director bought 5,161,290 shares at $7.75 ($39,999,998)
  4. 424B5 Offering Prospectus
  5. 8-K Event Material agreement · Other events
  6. 424B5 Offering Prospectus
  7. 8-K Event Results of operations
  8. 8-K Event Regulation FD disclosure · Other events
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. DEFA14A Proxy Proxy Materials
  20. ARS Other Annual Report to Security Holders

Page 12 of 19 · 365 filings